Table of Contents
Chapter 1. Global Antidepressant Drugs Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer's Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
Chapter 2. Executive Summary
2.1. Global Antidepressant Drugs Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Product
2.3.2. By Depressive Disorder
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Global Antidepressant Drugs Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Global Antidepressant Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Antidepressant Drugs Market Size & Forecasts by Product 2022-2032
5.1. Tricyclic Antidepressants
5.2. Selective Serotonin Reuptake Inhibitors
5.3. Serotonin Norepinephrine Reuptake Inhibitors
5.4. Monoamine Oxidase Inhibitors
5.5. Serotonin Antagonist and Reuptake Inhibitors
5.6. Others
Chapter 6. Global Antidepressant Drugs Market Size & Forecasts by Depressive Disorder 2022-2032
6.1. Major Depressive Disorder
6.2. Obsessive-Compulsive Disorder
6.3. Generalized Anxiety Disorder
6.4. Panic Disorder
6.5. Others
Chapter 7. Global Antidepressant Drugs Market Size & Forecasts by Region 2022-2032
7.1. North America Antidepressant Drugs Market
7.1.1. U.S. Antidepressant Drugs Market
7.1.1.1. Product breakdown size & forecasts, 2022-2032
7.1.1.2. Depressive Disorder breakdown size & forecasts, 2022-2032
7.1.2. Canada Antidepressant Drugs Market
7.2. Europe Antidepressant Drugs Market
7.2.1. U.K. Antidepressant Drugs Market
7.2.2. Germany Antidepressant Drugs Market
7.2.3. France Antidepressant Drugs Market
7.2.4. Spain Antidepressant Drugs Market
7.2.5. Italy Antidepressant Drugs Market
7.2.6. Rest of Europe Antidepressant Drugs Market
7.3. Asia-Pacific Antidepressant Drugs Market
7.3.1. China Antidepressant Drugs Market
7.3.2. India Antidepressant Drugs Market
7.3.3. Japan Antidepressant Drugs Market
7.3.4. Australia Antidepressant Drugs Market
7.3.5. South Korea Antidepressant Drugs Market
7.3.6. Rest of Asia Pacific Antidepressant Drugs Market
7.4. Latin America Antidepressant Drugs Market
7.4.1. Brazil Antidepressant Drugs Market
7.4.2. Mexico Antidepressant Drugs Market
7.4.3. Rest of Latin America Antidepressant Drugs Market
7.5. Middle East & Africa Antidepressant Drugs Market
7.5.1. Saudi Arabia Antidepressant Drugs Market
7.5.2. South Africa Antidepressant Drugs Market
7.5.3. Rest of Middle East & Africa Antidepressant Drugs Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Alkermes Plc
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. AbbVie Inc.
8.3.3. Eli Lilly and Company
8.3.4. F. Hoffmann-La Roche Ltd.
8.3.5. GlaxoSmithKline, Inc.
8.3.6. H. Lundbeck A/S
8.3.7. Merck KGAA
8.3.8. Pfizer Inc.
8.3.9. Teva Pharmaceutical Industries Ltd. (Actavis Generics)
8.3.10. Takeda Pharmaceutical Limited Company
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes